Cargando…

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay

Antiphospholipid syndrome (APS) is an autoimmune condition characterized by the presence of antiphospholipid antibodies (aPL) in subjects presenting with thrombosis and/or pregnancy loss. The currently used classification criteria were updated in the international consensus held in Sidney in 2005. V...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sciascia, Savino, Baldovino, Simone, Schreiber, Karen, Solfietti, Laura, Radin, Massimo, Cuadrado, Maria J., Menegatti, Elisa, Erkan, Doruk, Roccatello, Dario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947367/ https://www.ncbi.nlm.nih.gov/pubmed/27429595 http://dx.doi.org/10.1186/s12948-016-0043-2

Ejemplares similares

Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
por: Sciascia, Savino, et al.
Publicado: (2021)

The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents
por: Roccatello, Dario, et al.
Publicado: (2017)

Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort
por: Roccatello, Dario, et al.
Publicado: (2017)

Vedolizumab for the Management of Refractory Behçet’s Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease
por: Arbrile, Marta, et al.
Publicado: (2021)

Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing
por: Barinotti, Alice, et al.
Publicado: (2020)

The “4 plus 2” rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study
por: Roccatello, Dario, et al.
Publicado: (2017)

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
por: Sciascia, Savino, et al.
Publicado: (2019)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019)

Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience
por: Sciascia, Savino, et al.
Publicado: (2022)

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation
por: Radin, Massimo, et al.
Publicado: (2021)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016)

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies
por: Radin, Massimo, et al.
Publicado: (2021)

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
por: Sciascia, Savino, et al.
Publicado: (2021)

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab
por: Sciascia, Savino, et al.
Publicado: (2023)

Severe Multi-Organ Failure and Hypereosinophilia: When to Call It “Idiopathic”?
por: Radin, Massimo, et al.
Publicado: (2018)

Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update
por: Erkan, Doruk, et al.
Publicado: (2021)

New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing
por: Foddai, Silvia Grazietta, et al.
Publicado: (2023)

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App
por: Radin, Massimo, et al.
Publicado: (2022)

Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease
por: Sciascia, Savino, et al.
Publicado: (2023)

Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience
por: Roccatello, Dario, et al.
Publicado: (2020)

Recent advances in the management of systemic lupus erythematosus
por: Sciascia, Savino, et al.
Publicado: (2018)

Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review
por: Arbrile, Marta, et al.
Publicado: (2023)

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases
por: Valke, Lars L. F. G., et al.
Publicado: (2022)

Recognizing the new disorder “idiopathic hypocryoglobulinaemia” in patients with previously unidentified clinical conditions
por: Roccatello, Dario, et al.
Publicado: (2022)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Serum Biomarkers of Renal Fibrosis: A Systematic Review
por: Barinotti, Alice, et al.
Publicado: (2022)

The ABCs of antiphospholipid syndrome
por: Bahar Keleşoğlu Dinçer, Ayşe, et al.
Publicado: (2023)

Determination of Thrombogenicity Levels of Various Antiphospholipid Antibodies by a Modified Thrombin Generation Assay in Patients with Suspected Antiphospholipid Syndrome
por: Bradáčová, Pavla, et al.
Publicado: (2022)

Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome
por: Fenoglio, Roberta, et al.
Publicado: (2018)

Application of the thrombin generation assay in patients with antiphospholipid syndrome: A systematic review of the literature
por: Gehlen, Rachel, et al.
Publicado: (2023)

Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients
por: Sciascia, Savino, et al.
Publicado: (2022)

Renal involvement as a unique manifestation of hemophagocytic syndrome
por: Roccatello, Dario, et al.
Publicado: (2022)

COVID-19 and antiphospholipid antibodies
por: Butt, Ayesha, et al.
Publicado: (2022)

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTORApp—A Usability Study
por: Sciascia, Savino, et al.
Publicado: (2020)

Genetic Factors Associated with Rheumatoid Arthritis and Systemic Vasculitis: Evaluation of a Panel of Polymorphisms
por: Menegatti, Elisa, et al.
Publicado: (2009)

Hypercoagulability Evaluation in Antiphospholipid Syndrome without Anticoagulation Treatment with Thrombin Generation Assay: A Preliminary Study
por: Billoir, Paul, et al.
Publicado: (2021)

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study
por: Sciascia, Savino, et al.
Publicado: (2021)

Incidence of Antiphospholipid Syndrome: Is Estimation Currently Possible?
por: Ioannou, Yiannis, et al.
Publicado: (2023)

Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome
por: Stoots, Sarah Abramson, et al.
Publicado: (2019)

Validation of the Particle-Based Multi-Analyte Technology for Detection of Anti-PhosphatidylSerine/Prothrombin Antibodies
por: Radin, Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_et9db2to2bu1ffbd1lffs5e351